Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Environmental Science & Technology|July 8, 2021
Uptake and Toxicity of Respirable Carbon-Rich Uranium-Bearing Particles: Insights into the Role of Particulates in Uranium ToxicityEliane El Hayek, Sebastian Medina, Jimin Guo, et al.
ACS Nano|February 8, 2012
Delivery of small interfering RNA by peptide-targeted mesoporous silica nanoparticle-supported lipid bilayersCarlee E Ashley, Eric C Carnes, Katharine E Epler, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|November 17, 2009
Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing miceNripen Chanda, Para Kan, Lisa D Watkinson, et al.
Blood|June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Molecular Cancer Therapeutics|December 4, 2020
Development of Novel Antibody-Camptothecin ConjugatesRyan D Lyski, Lauren B Bou, Uland Y Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 4, 2016
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo releaseHitomi Hosoya, Andrey S Dobroff, Wouter H P Driessen, et al.
Nature Materials|April 19, 2011
The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersCarlee E Ashley, Eric C Carnes, Genevieve K Phillips, et al.
Environmental Health Perspectives|March 23, 2004
Identification of putative gene based markers of renal toxicityRupesh P Amin, Alison E Vickers, Frank Sistare, et al.
Bioconjugate Chemistry|July 2, 2013
A potent anti-CD70 antibody-drug conjugate combining a dimeric pyrrolobenzodiazepine drug with site-specific conjugation technologyScott C Jeffrey, Patrick J Burke, Robert P Lyon, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2023
Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligandsDaniela I Staquicini, Marina Cardó-Vila, Jimmy A Rotolo, et al.
Pageof 26